Bio-Rad Laboratories Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Bio-Rad Laboratories, Inc. income statement - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue2.572.672.802.922.552.312.29
Cost of Revenue1.191.241.231.281.111.051.07
Gross Profit1.381.431.571.641.44-1.051.22
Operating Expenses
Research & Development0.300.250.260.260.220.200.20
Selling, General & Administrative0.810.840.830.880.800.820.83
Operating Expenses1.111.091.091.141.021.031.03
Operating Income0.270.340.480.500.42-2.080.19
Other Income/Expense
Interest Income0.080.100.060.020.020.000.03
Interest Expense-0.050.050.040.00-0.020.000.02
Other Income/Expense0.00-1.24-5.204.930.00-4.370.32
Income
Income Before Tax-2.34-0.85-4.705.454.922.260.51
Income Tax Expense-0.50-0.21-1.081.191.100.500.15
Net Income-1.84-0.64-3.634.253.811.760.37
Net Income - Continuous Operations-1.84-0.64-3.634.250.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA0.42-0.65-4.535.590.562.240.67
EBIT0.27-0.80-4.675.450.422.280.54
Depreciation & Amortization0.150.150.140.140.14-0.040.00
Earnings Per Share
Basic EPS-65.00-22.00-122.00142.00128.0059.0012.00
Diluted EPS-65.00-22.00-122.00141.00126.0058.0012.00
Basic Shares Outstanding0.030.030.030.030.030.030.03
Diluted Shares Outstanding0.030.030.030.030.030.030.03